Geremy Lowe

Ph.D. Student
B.A. in Ethnic Studies (University of California, Berkeley) and A.A. in Journalism (Laney College)

Social advocacy has been the center of creating access to housing, jobs, pharmaceutical drugs, and other human rights for folks living with HIV/AIDS. For the past two decades, advocacy for HIV/AIDS medications focuses on international regions, particularly countries in Africa. The narrative of those within the Americas living with HIV/AIDS is on the verge of erasure. Translating social advocacy into an analysis of Black, queer Americans' social mobilization and organizing during the HIV/AIDS epidemic in the United States can be utilized to create new policies and laws that would place underserved communities at the forefront of healthcare access.

As a Black, queer American, I know first-hand the effects historical research can have on the future of health for those within my community. As society grapples with the intersections of COVID-19 and HIV, there is an emergence of research on HIV vaccines that would become accessible, particularly to those with access. Epidemiologic studies and social advocacy for underserved populations in the United States bridge science, health, and social issues. Consequently, I envision myself as a public health historian, aiding government officials in tracing these disparities and proposing solutions to advance health equity. Additionally, I see myself as a professor assisting students in developing their appreciation for social movements' thought-provoking and influential nature and their centrality to ending health disparities in the United States.